JP2014526519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014526519A5 JP2014526519A5 JP2014530924A JP2014530924A JP2014526519A5 JP 2014526519 A5 JP2014526519 A5 JP 2014526519A5 JP 2014530924 A JP2014530924 A JP 2014530924A JP 2014530924 A JP2014530924 A JP 2014530924A JP 2014526519 A5 JP2014526519 A5 JP 2014526519A5
- Authority
- JP
- Japan
- Prior art keywords
- range
- pharmaceutical composition
- mdj
- nanocarriers
- size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IPWBXORAIBJDDQ-UHFFFAOYSA-N methyl 2-hexyl-3-oxocyclopentane-1-carboxylate Chemical compound CCCCCCC1C(C(=O)OC)CCC1=O IPWBXORAIBJDDQ-UHFFFAOYSA-N 0.000 claims 3
- 239000002539 nanocarrier Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 229940097362 Cyclodextrins Drugs 0.000 claims 1
- -1 cholesteryl ester Chemical class 0.000 claims 1
- 239000000412 dendrimer Substances 0.000 claims 1
- 229920000736 dendritic polymer Polymers 0.000 claims 1
- 239000007908 nanoemulsion Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Claims (1)
- 医薬として許容される溶媒、およびメチルジヒドロジャスモネート（ＭＤＪ）を含有する複数のナノキャリアまたはマイクロキャリアを含む医薬組成物であって、
ナノキャリアまたはマイクロキャリアは、シクロデキストリンまたはデンドリマーから形成される、あるいはリン脂質層に囲まれたコレステリルエステルのコアを含む合成ナノエマルジョン粒子（ＬＤＥ）であり；
ナノキャリアは、１ナノメートル（ｎｍ）から５００ｎｍの範囲のサイズを有する；あるいは
マイクロキャリアは、１ミクロンから１００ミクロンの範囲のサイズを有する；そして
医薬組成物は、１ｎＭから１Μの範囲の濃度のＭＤＪを有する、前記医薬組成物。
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161535836P | 2011-09-16 | 2011-09-16 | |
| US61/535,836 | 2011-09-16 | ||
| US201161555690P | 2011-11-04 | 2011-11-04 | |
| US61/555,690 | 2011-11-04 | ||
| US201261603042P | 2012-02-24 | 2012-02-24 | |
| US61/603,042 | 2012-02-24 | ||
| PCT/IB2012/000364 WO2012114196A1 (pt) | 2011-02-25 | 2012-02-27 | Formulação farmacêutica compreendendo compostos da família dos jasmonatos |
| IBPCT/IB2012/000364 | 2012-02-27 | ||
| US201261607318P | 2012-03-06 | 2012-03-06 | |
| US61/607,318 | 2012-03-06 | ||
| US201261612774P | 2012-03-19 | 2012-03-19 | |
| US61/612,774 | 2012-03-19 | ||
| PCT/US2012/055757 WO2013040556A1 (en) | 2011-09-16 | 2012-09-17 | Compositions of jasmonate compounds and methods of use |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017117103A Division JP2017222659A (ja) | 2011-09-16 | 2017-06-14 | ジャスモネート化合物の組成物および使用方法 |
| JP2019000256A Division JP2019077702A (ja) | 2011-09-16 | 2019-01-04 | ジャスモネート化合物の組成物および使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014526519A JP2014526519A (ja) | 2014-10-06 |
| JP2014526519A5 true JP2014526519A5 (ja) | 2015-11-12 |
Family
ID=47883826
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014530924A Pending JP2014526519A (ja) | 2011-09-16 | 2012-09-17 | ジャスモネート化合物の組成物および使用方法 |
| JP2017117103A Pending JP2017222659A (ja) | 2011-09-16 | 2017-06-14 | ジャスモネート化合物の組成物および使用方法 |
| JP2019000256A Pending JP2019077702A (ja) | 2011-09-16 | 2019-01-04 | ジャスモネート化合物の組成物および使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017117103A Pending JP2017222659A (ja) | 2011-09-16 | 2017-06-14 | ジャスモネート化合物の組成物および使用方法 |
| JP2019000256A Pending JP2019077702A (ja) | 2011-09-16 | 2019-01-04 | ジャスモネート化合物の組成物および使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8883220B2 (ja) |
| EP (1) | EP2755643B1 (ja) |
| JP (3) | JP2014526519A (ja) |
| KR (2) | KR20190108189A (ja) |
| CN (2) | CN107970213A (ja) |
| BR (1) | BR112014006153A2 (ja) |
| CA (1) | CA2848219A1 (ja) |
| HK (1) | HK1254825A1 (ja) |
| MX (1) | MX370253B (ja) |
| RU (1) | RU2014114931A (ja) |
| WO (1) | WO2013040556A1 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140220132A1 (en) * | 2011-02-25 | 2014-08-07 | José E. Fehr Pereira Lopes | Pharmaceutical Formulation Comprising Compounds of the Jasmonate Family |
| KR20190108189A (ko) | 2011-09-16 | 2019-09-23 | 나노케어 테크놀로지스 인코퍼레이티드 | 자스모네이트 화합물의 조성물 및 이의 용도 |
| JP2014122191A (ja) * | 2012-12-21 | 2014-07-03 | L'oreal Sa | 油、非イオン界面活性剤及びジャスモン酸誘導体を含む化粧品組成物 |
| US11166886B2 (en) | 2012-12-21 | 2021-11-09 | L'oreal | Cosmetic composition |
| US20150230462A1 (en) * | 2014-01-15 | 2015-08-20 | New Biology, Inc. | Methods for improving germination and stress tolerance characteristics with jasmonates |
| JP2018502855A (ja) * | 2014-12-31 | 2018-02-01 | ナノケア テクノロジーズ，インコーポレイティド | ジャスモネート誘導体及びそれらの組成物 |
| US20200297620A1 (en) * | 2016-03-28 | 2020-09-24 | Vidac Pharma Ltd | Stable pharmaceutical compositions for topical administration and uses thereof |
| US10410943B2 (en) | 2016-10-13 | 2019-09-10 | Asm Ip Holding B.V. | Method for passivating a surface of a semiconductor and related systems |
| EP3565555A4 (en) * | 2016-11-07 | 2021-03-17 | VIDAC Pharma Ltd. | USE OF HEXKINASE-2 / MITOCHONDRIAL DISCONNECTORS FOR TREATMENT OF HEXKINASE-2 (HC2) EXPRESSING CANCER DISEASES |
| US10682346B2 (en) | 2016-11-07 | 2020-06-16 | Vidac Pharma Ltd. | Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses |
| KR102275801B1 (ko) * | 2019-12-24 | 2021-07-09 | 경희대학교 산학협력단 | 시스-자스몬을 포함하는 바이오필름 형성 억제용 조성물 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE124422T1 (de) | 1989-04-12 | 1995-07-15 | Procter & Gamble | Festes verbraucherprodukt, welches feinteilige cyclodextrin-komplexe enthält. |
| CA2013485C (en) | 1990-03-06 | 1997-04-22 | John Michael Gardlik | Solid consumer product compositions containing small particle cyclodextrin complexes |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| JP3568325B2 (ja) | 1996-07-12 | 2004-09-22 | 株式会社ノエビア | 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料 |
| JP3596835B2 (ja) | 1996-08-13 | 2004-12-02 | 株式会社ノエビア | 養毛剤 |
| CA2293663A1 (en) | 1997-06-09 | 1998-12-17 | The Procter & Gamble Company | Perfumed compositions and methods for reducing body odors and excess moisture |
| US6790815B1 (en) | 1998-07-10 | 2004-09-14 | Procter & Gamble Company | Amine reaction compounds comprising one or more active ingredient |
| CA2274873A1 (en) | 1999-07-06 | 2001-01-06 | Satinder Gidda | Methods and compositions for modulating flowering |
| EP1372739A4 (en) | 2001-03-08 | 2005-10-19 | Targesome Inc | STABILIZED THERAPEUTIC AND IMAGING AGENTS |
| US6469061B1 (en) * | 2001-04-04 | 2002-10-22 | Ramot University Authority For Applied Research And Industrial Development Limited | Jasmonate pharmaceutical composition for treatment of cancer |
| US20030224024A1 (en) | 2002-02-04 | 2003-12-04 | Jean-Luc Leveque | Compositions comprising cyclopentane derivatives and their use |
| US20040209795A1 (en) * | 2003-04-21 | 2004-10-21 | Vlad Florin Joseph | VOC-free microemulsions |
| EP1689696A2 (en) | 2003-12-02 | 2006-08-16 | Ramot at Tel-Aviv University Ltd. | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
| KR100789343B1 (ko) | 2004-09-07 | 2007-12-28 | 주식회사 엘지생활건강 | 화장용 분체, 그의 제조방법 및 이를 함유하는 메이컵화장품 조성물 |
| WO2006056308A2 (de) | 2004-11-25 | 2006-06-01 | Merck Patent Gmbh | Flavonoid-komplexe mit cyclodextrinen |
| US7258878B2 (en) | 2004-12-20 | 2007-08-21 | Kimberly-Clark Worldwide, Inc. | Anti-microbial composition and methods of use thereof |
| ES2265291B1 (es) | 2005-07-22 | 2008-03-01 | Universidad De Alcala | Nuevos dendrimeros carbosilanos, su preparacion y sus usos. |
| WO2007066337A2 (en) | 2005-12-07 | 2007-06-14 | Sepal Pharma Ltd. | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
| EP2402321A3 (en) | 2005-12-07 | 2012-02-29 | Ramot at Tel Aviv University, Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| WO2007103336A2 (en) | 2006-03-06 | 2007-09-13 | The Board Of Trustees Operating | Micro-encapsulation of volatile compounds into cyclodextrins |
| WO2007145663A1 (en) | 2006-06-13 | 2007-12-21 | Cargill, Incorporated | Large-particle cyclodextrin inclusion complexes and methods of preparing same |
| WO2008007367A1 (en) | 2006-07-10 | 2008-01-17 | Ramot At Tel-Aviv University Ltd. | Combination methods of treating cancer |
| BRPI0604024A (pt) | 2006-09-01 | 2008-04-22 | Beyond Lifescience Pesquisa De | alimentos para a prevenção do cáncer e composições farmacêuticas à base do jasmonato |
| US20100160623A1 (en) * | 2006-12-27 | 2010-06-24 | Cargill, Incorporated | Cyclodextrin inclusion complexes and methods of preparing same |
| WO2009019693A2 (en) | 2007-08-07 | 2009-02-12 | Sepal Pharma Sa | Analgesic effect of jasmonate derivatives |
| ES2731881T3 (es) | 2007-09-25 | 2019-11-19 | Formulex Pharma Innovations Ltd | Composiciones que comprenden compuestos activos lipófilos y método para su preparación |
| GB0721761D0 (en) | 2007-11-06 | 2007-12-19 | Plant Bioscience Ltd | Compositions and methods for synergistic manipulation of plant and insect defences |
| WO2009067404A2 (en) | 2007-11-19 | 2009-05-28 | New Biology, Inc. | Methods for improving flowering characteristics using methyl dihydrojasmonate |
| KR101199672B1 (ko) * | 2008-02-01 | 2012-11-09 | 마리 케이 인코포레이티드 | 방향성 피부활성 성분을 사용하여 피부를 치료하는 방법 |
| ES2328002B2 (es) | 2008-02-29 | 2010-03-29 | Universidad De Alicante | Uso combinado de metil-jasmonato y ciclodextrinas para la produccion de resveratrol. |
| BRPI0804172A2 (pt) * | 2008-07-15 | 2010-07-06 | Pereira Lopes Jose Emilio Fehr | compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos |
| AU2010258223B2 (en) * | 2009-06-09 | 2014-12-04 | Ramot At Tel-Aviv University Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| CN101818100B (zh) * | 2010-04-15 | 2012-06-06 | 上海应用技术学院 | 聚氰基丙烯酸丁酯包覆大花茉莉香精胶囊的制备方法 |
| ES2610425T3 (es) | 2010-08-27 | 2017-04-27 | Neonc Technologies Inc. | Composiciones farmacéuticas que comprenden carbamatos de alcohol perilílico |
| US20140220132A1 (en) | 2011-02-25 | 2014-08-07 | José E. Fehr Pereira Lopes | Pharmaceutical Formulation Comprising Compounds of the Jasmonate Family |
| KR20190108189A (ko) | 2011-09-16 | 2019-09-23 | 나노케어 테크놀로지스 인코퍼레이티드 | 자스모네이트 화합물의 조성물 및 이의 용도 |
| EP2583998B1 (en) * | 2011-10-21 | 2018-02-28 | Borealis AG | Polyethylene composition with high rapid crack propagation resistance and pressure resistance |
| US9187402B2 (en) | 2012-06-14 | 2015-11-17 | North Carolina Agricultural And Technical State University | Aspirin derivatives and uses thereof |
| EP2872180B1 (en) | 2012-07-10 | 2018-08-08 | baseclick GmbH | Anandamide-modified nucleic acid molecules |
| JP2018502855A (ja) | 2014-12-31 | 2018-02-01 | ナノケア テクノロジーズ，インコーポレイティド | ジャスモネート誘導体及びそれらの組成物 |
-
2012
- 2012-09-17 KR KR1020197026840A patent/KR20190108189A/ko not_active Application Discontinuation
- 2012-09-17 MX MX2014003301A patent/MX370253B/es active IP Right Grant
- 2012-09-17 JP JP2014530924A patent/JP2014526519A/ja active Pending
- 2012-09-17 BR BR112014006153-0A patent/BR112014006153A2/pt not_active Application Discontinuation
- 2012-09-17 CA CA2848219A patent/CA2848219A1/en not_active Abandoned
- 2012-09-17 CN CN201710976693.1A patent/CN107970213A/zh active Pending
- 2012-09-17 KR KR1020147010217A patent/KR102023132B1/ko active IP Right Grant
- 2012-09-17 CN CN201280056298.7A patent/CN104203222A/zh active Pending
- 2012-09-17 EP EP12832060.3A patent/EP2755643B1/en active Active
- 2012-09-17 RU RU2014114931/15A patent/RU2014114931A/ru not_active Application Discontinuation
- 2012-09-17 US US13/621,570 patent/US8883220B2/en active Active - Reinstated
- 2012-09-17 WO PCT/US2012/055757 patent/WO2013040556A1/en active Application Filing
-
2014
- 2014-10-27 US US14/525,199 patent/US9592305B2/en active Active
-
2017
- 2017-02-15 US US15/433,581 patent/US10328155B2/en active Active - Reinstated
- 2017-06-14 JP JP2017117103A patent/JP2017222659A/ja active Pending
-
2018
- 2018-10-31 HK HK18113916.4A patent/HK1254825A1/zh unknown
-
2019
- 2019-01-04 JP JP2019000256A patent/JP2019077702A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014526519A5 (ja) | ||
| Zinchenko et al. | Single-chain compaction of long duplex DNA by cationic nanoparticles: modes of interaction and comparison with chromatin | |
| Deng et al. | Superparamagnetic high-magnetization microspheres with an Fe3O4@ SiO2 core and perpendicularly aligned mesoporous SiO2 shell for removal of microcystins | |
| Borm et al. | Nanoparticles in drug delivery and environmental exposure: same size, same risks? | |
| JP2013511813A5 (ja) | ||
| JP2012085643A5 (ja) | ||
| JP2012131827A5 (ja) | ||
| CL2013003331A1 (es) | Tableta de liberacion inmediata a prueba de alteracion que comprende (i) una matriz, y (ii) una pluralidad de material particulado, que comprende un opiaceo y un polimero de oxido de polietileno de mas de 20.000 g/mol, donde el multiparticulado forma una fase discontinua dentro de la matriz. | |
| JP2011525477A5 (ja) | ||
| JP2015519403A5 (ja) | ||
| JP2012500004A5 (ja) | ||
| JP2015525757A5 (ja) | ||
| JP2014530219A5 (ja) | ||
| BRPI1013021A2 (pt) | "material compósito que compreende nanopartículas, e produção de camadas fotoativas que contêm nanopartículas semicondutoras quaternárias, pentanárias ou de ordem mais alta" | |
| JP2014523540A5 (ja) | ||
| JP2013535021A5 (ja) | ||
| RU2014114931A (ru) | Композиции соединений жасмонатов и способы применения | |
| JP2012101354A5 (ja) | ||
| JP2013047264A5 (ja) | ||
| JP2013511602A5 (ja) | ||
| JP2014501688A5 (ja) | ||
| JP2014500802A5 (ja) | ||
| JP2015510935A5 (ja) | ||
| JP2013516469A5 (ja) | ||
| JP2011519893A5 (ja) |